anacetrapib
Showing 1 - 7 of 7
Atherosclerotic Cardiovascular Disease Trial in Oxford (Anacetrapib, Placebo anacetrapib)
Active, not recruiting
- Atherosclerotic Cardiovascular Disease
- Anacetrapib
- Placebo anacetrapib
-
Oxford, Oxfordshire, United KingdomCTSU, University of Oxford
Mar 1, 2022
Hyperlipoproteinemia Type II, Hypercholesterolemia, Familial Trial (Anacetrapib, Placebo)
Completed
- Hyperlipoproteinemia Type II
- Hypercholesterolemia, Familial
- Anacetrapib
- Placebo
- (no location specified)
Sep 27, 2019
Anacetrapib on Vascular Function and Arterial Stiffness
Completed
- Atherosclerotic Cardiovascular Disease
- Vascular Disease
- Anacetrapib
- +2 more
-
Cambridge, Cambridgeshire, United KingdomClinical Investigation Ward, Addenbrooke's Hospital
Aug 15, 2018
Heterozygous Familial Hypercholesterolemia (HeFH) Trial (Anacetrapib, Placebo for anacetrapib)
Completed
- Heterozygous Familial Hypercholesterolemia (HeFH)
- Anacetrapib
- Placebo for anacetrapib
- (no location specified)
Apr 22, 2016
Dyslipidemia Trial (anacetrapib)
Completed
- Dyslipidemia
- anacetrapib
- (no location specified)
Oct 12, 2015
Dyslipidemia Trial (anacetrapib, Comparator: atorvastatin, Comparator: Placebo)
Completed
- Dyslipidemia
- anacetrapib
- +2 more
- (no location specified)
May 5, 2015
Dyslipidemia Trial (anacetrapib, Comparator: atorvastatin, Comparator: to MK0859)
Completed
- Dyslipidemia
- anacetrapib
- +3 more
- (no location specified)
Jun 3, 2015